FDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab for Sézary Syndrome Read more
Newleos Therapeutics Raises $93.5M in Oversubscribed Series A to Advance Neuropsychiatric Disorder Treatments Read more